Burney CO Rigel Pharmaceuticals Inc Transaction History

Burney CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$1.1 - $12.2 $3,300 - $36,600	3,000 Added 9.38%	35,000 $41,000
Q4 2019 Feb 14, 2020	BUY	$1.6 - $2.43 $51,200 - $77,760	32,000 New	32,000 $68,000
Q3 2018 Nov 13, 2018	SELL	$2.6 - $3.59 $65,000 - $89,750	-25,000 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$2.83 - $4.11 $70,750 - $102,750	25,000 New	25,000 $71,000
Q1 2018 May 08, 2018	SELL	$3.54 - $4.54 $88,500 - $113,500	-25,000 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$3.23 - $4.3 $80,750 - $107,500	25,000	25,000 $97,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

Stay updated on Burney CO with notifications on news.